
Revolutionizing Cancer Treatment: Poseida Therapeutics’ Promising Progress at ASH Annual Meeting
Additional Data from Poseida Therapeutics Shows Promising Results in Multiple Myeloma Treatment Optimized Lymphodepletion Arm Demonstrates Consistent Cellular Expansion New profiling of patient responses from Poseida Therapeutics’ optimized lymphodepletion arm (Arm C) has shown consistent expansion and persistence of P-BCMA-ALLO1 cellular therapy across different subgroups. This data is a promising sign for the ongoing Phase…